What causes placental bleeding when placental tissue is present on the cervical os (cervical opening)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Placental bleeding when placental tissue is present on the cervical os (placenta previa) occurs because the placenta has implanted in an abnormal location over or near the cervical opening, causing disruption of the attachment between the placenta and uterine wall and tearing of delicate blood vessels as the cervix dilates. This condition is a significant risk to both maternal and fetal health, and its management is crucial to prevent uncontrolled vaginal bleeding and potential complications.

Key Factors Contributing to Placental Bleeding

  • The lower uterine segment must stretch and thin during the third trimester and early labor, which can disrupt the placental attachment and lead to bleeding 1.
  • The cervical area has an abundant blood supply, and when the placenta is implanted in this location, there is no mechanism for the blood vessels to contract and seal off when disrupted, leading to severe bleeding 1.
  • The risk of placenta previa and associated bleeding is increased in women with a history of cesarean delivery, with the risk increasing with the number of prior cesarean deliveries 1.

Clinical Implications and Management

  • Placenta previa is a significant risk factor for placenta accreta spectrum disorder (PASD), which can lead to severe and life-threatening hemorrhage during delivery 1.
  • Accurate antenatal diagnosis and planning for delivery at an experienced center are essential to reduce maternal morbidity and mortality 1.
  • Management of delivery may involve planned cesarean delivery with or without hysterectomy, depending on the suspected severity of PASD, and a contingency plan for emergent delivery should be in place 1.

From the Research

Placental Bleeding Causes

  • Placental tissue on the cervical os can cause placental bleeding due to the placenta covering or being proximate to the internal cervical os, leading to bleeding when the cervix dilates or when the placenta separates from the uterus 2.
  • The presence of placental tissue on the cervical os can lead to bleeding due to the disruption of the placental attachment to the uterus, resulting in maternal and fetal complications 3, 4.

Risk Factors for Placental Bleeding

  • Prior cesarean delivery, advanced maternal age, and smoking are key risk factors for placenta previa, which can cause placental bleeding 2.
  • The use of tocolytic agents to stop associated contractions in cases of third-trimester bleeding may not increase the risk of maternal morbidity or mortality, but may prolong pregnancy and increase birth weight 4, 5.

Management of Placental Bleeding

  • Expectant management of placenta previa, including the use of tocolytics, blood transfusion, and cesarean section, can be effective in managing placental bleeding 3, 4.
  • A planned cesarean delivery is recommended in cases of placenta previa that persist into the late third trimester 2.
  • The optimal timing of antenatal corticosteroids in women with bleeding placenta previa or low-lying placenta can be optimized by identifying women at low risk of imminent delivery 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Placenta Previa.

Clinical obstetrics and gynecology, 2025

Research

Placenta previa: an analysis of three years experience.

American journal of perinatology, 1985

Research

Is tocolysis safe in the management of third-trimester bleeding?

American journal of obstetrics and gynecology, 1999

Research

The effect of tocolytic use in the management of symptomatic placenta previa.

American journal of obstetrics and gynecology, 1995

Research

Optimal timing of antenatal corticosteroids in women with bleeding placenta previa or low-lying placenta.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.